A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Gilead Sciences
Hackensack Meridian Health
Artiva Biotherapeutics, Inc.
University Hospital, Caen
Stanford University
Gilead Sciences
Hoffmann-La Roche
Allogene Therapeutics
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Gilead Sciences
Goethe University
H. Lee Moffitt Cancer Center and Research Institute
Gilead Sciences
French Innovative Leukemia Organisation
Gilead Sciences
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Fate Therapeutics
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
University of Liverpool
Vanderbilt-Ingram Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
German CLL Study Group
German CLL Study Group
Gilead Sciences
Hoffmann-La Roche
Cedars-Sinai Medical Center
Stanford University
University of Giessen
Gilead Sciences
St. Petersburg State Pavlov Medical University
M.D. Anderson Cancer Center
Gilead Sciences
University of Alabama at Birmingham
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota